The U.S. drug regulator declared that the shortage of weight-loss medications Wegovy and Ozempic has been resolved, Danish pharma giant Novo Nordisk said.

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk's weight-loss medications Wegovy and Ozempic has been resolved, according to its website. The FDA announcement confirms ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and projected demand in the country, the Danish pharmaceutical company said.

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

I attended a lunch with a gaggle of middle-aged women, we spent a leisurely two hours laughing and tucking into a traditional ...

Donald Trump hosted meals with dozens of the corporate leaders during the presidential transition, in a lucrative venture.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Dolores Catania is thinking about quitting Ozempic. In a recent interview with Hello!, the Real Housewives of New Jersey star ...

A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause three potentially blinding eye conditions. The research identified ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...